Cargando…
Basal and stimulated calcitonin for the diagnosis of medullary thyroid cancer: updated thresholds and safety assessment
PURPOSE: Reliable cut-offs for basal (bCT) and calcium stimulated calcitonin (casCT) are needed for an early and accurate diagnosis of medullary thyroid cancer (MTC). PATIENTS AND METHODS: Fifty-four new patients with nodular goiter were enrolled and analysed together with those previously published...
Autores principales: | Fugazzola, L., Di Stefano, M., Censi, S., Repaci, A., Colombo, C., Grimaldi, F., Magri, F., Pagotto, U., Iacobone, M., Persani, L., Mian, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878259/ https://www.ncbi.nlm.nih.gov/pubmed/32656666 http://dx.doi.org/10.1007/s40618-020-01356-9 |
Ejemplares similares
-
Basal and Calcium-Stimulated Procalcitonin for the Diagnosis of Medullary Thyroid Cancers: Lights and Shadows
por: Censi, Simona, et al.
Publicado: (2021) -
Serum calcitonin estimation in medullary thyroid cancer: basal or stimulated levels?
por: Daumerie, Chantal, et al.
Publicado: (2013) -
Clinical and Genetic Features of a Large Monocentric Series of Familial Non-Medullary Thyroid Cancers
por: Cirello, Valentina, et al.
Publicado: (2021) -
The role of procalcitonin in the follow-up of medullary thyroid cancer
por: Censi, Simona, et al.
Publicado: (2022) -
Serum calcitonin negative Medullary thyroid carcinoma
por: Sand, Michael, et al.
Publicado: (2006)